High levels of Ship2 have been encountered in certain breast cancer cell lines and tissue, where Ship2 knockdown induces decreased AKT-phosphorylation, as well as reduced tumorigenesis in vivo and cell proliferation in culture [4]. This evidence concerns the gene INPPL1 and breast cancer.